Lilly is committed to making life better for people living with diabetes and obesity through developing medicines that change the way healthcare providers can treat these diseases. The development and approvals of Mounjaro and Zepbound demonstrate our continued commitment to this mission. We are guided every day by our founder Colonel Eli Lilly's saying when, over a hundred years ago, he affixed his signature as the logo to our medicines: "If it bears a red Lilly, it's right."
An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro and Zepbound
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.